Bader; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bader; Michael.The latest application filed is for "methods for modulating pigmentation by angiotensin-converting enzyme 2 modulation".

Company Profile

4.10.16

Bader; Michael - Berlin DE
Bader; Michael - Arni AG CH
Bader; Michael - Hamburg DE
Bader; Michael - Aldingen DE
Bader; Michael - Copiague NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Methods for modulating pigmentation by angiotensin-converting enzyme 2 modulation Grant 11,337,909 - Bader , et al. May 24, 2	2022-05-24
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same Grant 11,028,104 - Bader , et al. June 8, 2	2021-06-08
Methods For Modulating Pigmentation By Angiotensin-converting Enzyme 2 Modulation App 20200360258 - Bader; Michael ; et al.	2020-11-19
Xanthine Derivatives, Their Use As A Medicament, And Pharmaceutical Preparations Comprising The Same App 20200262847 - BADER; Michael ; et al.	2020-08-20
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same Grant 10,683,309 - Bader , et al.	2020-06-16
Xanthine Derivatives, Their Use As A Medicament, And Pharmaceutical Preparations Comprising The Same App 20190161503 - BADER; Michael ; et al.	2019-05-30
Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same Grant 10,214,530 - Bader , et al. Feb	2019-02-26
Xanthine Derivatives, Their Use As A Medicament, And Pharmaceutical Preparations Comprising The Same App 20180051025 - BADER; Michael ; et al.	2018-02-22
Stabilized high-voltage power supply Grant 9,041,288 - Bader May 26, 2	2015-05-26
Stabilized High-voltage Power Supply App 20140097747 - Bader; Michael	2014-04-10
Gpnmb/osteoactivin As A Biomarker And Drug Target In Cardiac Diseases App 20140031411 - Bader; Michael ; et al.	2014-01-30
Method for modulating, treating and/or preventing metabolic syndrome using MAS-G-protein-coupled receptor agonists Grant 8,586,054 - Souza Dos Santos , et al. November 19, 2	2013-11-19
Use of Mas-G-Protein-Coupled Receptor Agonists in the Treatment of the Metabolic Syndrome, Its Components and its Complications App 20090221498 - Souza Dos Santos; Robson Augusto ; et al.	2009-09-03
Shrna And Sirna And Mirna Expression In A Living Organism Under Control Of A Codon-optimized Repressor Gene App 20090025097 - SEIBLER; Jost ; et al.	2009-01-22
Methods and Kits For the Prediction of Therapeutic Success and Recurrence Free Survival In Cancer Therapy App 20080299550 - Munnes; Marc ; et al.	2008-12-04
Use of Tryptophan Derivatives for the Specific Cytostatic Treatment of Serotonin-Producing Tumors App 20070299128 - Walther; Diego ; et al.	2007-12-27
Electric switch Grant 7,242,390 - Bader , et al. July 10, 2	2007-07-10
Neuronally expressed tryptophane hydroxylase and its use App 20060275759 - Walther; Diego ; et al.	2006-12-07
Electric switch App 20060124438 - Bader; Michael ; et al.	2006-06-15
Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency Grant 7,049,336 - Walther , et al. May 23, 2	2006-05-23
Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue App 20040208857 - Bader, Michael ; et al.	2004-10-21
Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors App 20040097576 - Walther, Diego ; et al.	2004-05-20
Method for diagnosing neuronal deseases and for treating primary hemostasis deficiency App 20040014656 - Walther, Deigo ; et al.	2004-01-22
Shock absorbing fixture Grant 6,055,998 - Bader May 2, 2	2000-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.